Detalles de la búsqueda
1.
Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non-interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials.
Eur J Haematol
; 108(2): 133-144, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714555
2.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Int J Cancer
; 148(6): 1478-1488, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33038277
3.
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR.
Curr Med Res Opin
; 38(12): 2191-2199, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047998
4.
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.
J Cancer Res Clin Oncol
; 144(3): 559-569, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29285668
5.
Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO).
Leuk Lymphoma
; 45(9): 1821-7, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15223642
Resultados
1 -
5
de 5
1
Próxima >
>>